Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...

Myasthenia Gravis ll: Pathophysiology

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...

Myasthenia Gravis: Overview and Treatment

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...

Disorders of the Skeletal Muscle

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...

Myasthenia Gravis: Diagnostic Tests

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...

Skeletal Muscle Relaxants: Adverse Effects

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Budd-Chiari Syndrome: Update on Classification and Intravascular US.

Radiographics : a review publication of the Radiological Society of North America, Inc·2025

Same author

Dietary polyphenol assessment for aging research.

Aging·2025

Same author

Dietary associations with reduced epigenetic age: a secondary data analysis of the methylation diet and lifestyle study.

Aging·2025

Same author

Enhancing your practice: debriefing in interventional radiology.

CVIR endovascular·2024

Same author

Survey of New Zealand Poultry Consumers' Handling of Raw Poultry and Food Safety Awareness To Provide Insight into Risk Factors for Campylobacteriosis.

Journal of food protection·2021

Same author

Furin Protease: From SARS CoV-2 to Anthrax, Diabetes, and Hypertension.

The Permanente journal·2020

Search research articles

Related Experiment Video

Updated: May 5, 2026

Author Spotlight: Advanced Integrated Model for Sepsis-Induced Myopathy and Single-Cell Metabolic Analysis

Author Spotlight: Advanced Integrated Model for Sepsis-Induced Myopathy and Single-Cell Metabolic Analysis

Published on: June 14, 2024

Statin-induced Myopathy.

Kara Fitzgerald¹, Elizabeth Redmond, Cathryn Harbor

¹Kara Fitzgerald, ND, is coauthor of Case Studies in Integrative and Functional Medicine and is on faculty for the Institute for Functional Medicine, Gig Harbor, Washington.

Global Advances in Health and Medicine

|November 27, 2013

Summary

This summary is machine-generated.

Statin cholesterol drugs can cause mitochondrial myopathy, a muscle condition linked to CoQ10 depletion. This occurs even with normal creatine kinase levels, indicating a need for further diagnostic evaluation.

Keywords:

HMG-CoA vitamin D Heart disease cardiovascular cholesterol coQ10 diet exercise myopathy statin therapy

More Related Videos

In Situ Immunofluorescent Staining of Autophagy in Muscle Stem Cells

In Situ Immunofluorescent Staining of Autophagy in Muscle Stem Cells

Published on: June 12, 2017

Related Experiment Videos

Last Updated: May 5, 2026

Author Spotlight: Advanced Integrated Model for Sepsis-Induced Myopathy and Single-Cell Metabolic Analysis

Author Spotlight: Advanced Integrated Model for Sepsis-Induced Myopathy and Single-Cell Metabolic Analysis

Published on: June 14, 2024

In Situ Immunofluorescent Staining of Autophagy in Muscle Stem Cells

In Situ Immunofluorescent Staining of Autophagy in Muscle Stem Cells

Published on: June 12, 2017

Area of Science:

Cardiovascular Medicine
Mitochondrial Biology
Pharmacology

Background:

Heart disease is a leading cause of death in the US, with significant economic costs.
Statin therapy, like atorvastatin, is a primary intervention for cardiovascular disease (CVD).
Statins are widely prescribed but can induce side effects indicating mitochondrial distress.

Observation:

Statin-induced myopathy, including myalgia, is a recognized side effect.
Histological findings suggest mitochondrial dysfunction, termed mitochondrial myopathy.
Mitochondrial myopathy is linked to statin-induced Coenzyme Q10 (CoQ10) depletion.

Findings:

The case study suggests statin-induced mitochondrial myopathy.
Diagnostic indicators included mitochondrial-specific organic acids and low serum CoQ10.
These findings were present despite normal serum creatine kinase (CK) levels.

Implications:

Mitochondrial myopathy may occur with statin use, even with normal CK.
CoQ10 depletion is a potential mechanism for statin-induced mitochondrial dysfunction.
Further research into statin-induced mitochondrial myopathy and CoQ10 supplementation is warranted.